Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8690548 | Pediatric Neurology | 2017 | 6 Pages |
Abstract
Patients with hemato-oncological disease and secondary intracranial hypertension may not develop typical symptomatology. Thus, diagnosis and recognition of this entity among this cohort may be difficult. Associated factors are diverse and do not show an obvious causal relationship. A high index of suspicion must be maintained for diagnosis, because a favorable outcome is expected with prompt treatment. Acetazolamide is effective as a first-line therapy and caused few side effects.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Miguel Ángel MD, Verónica MD, Maitane MD, Anna MD, PhD, Saioa MD, Ignacio MD, Montesclaros MD, Saray MD, Lara MD, David MD,